Geralyn G DeGuzman

Title: Innovations by Geralyn G DeGuzman

Introduction

Geralyn G DeGuzman is a prominent inventor based in Daly City, CA (US). She has made significant contributions to the field of pharmaceutical compositions, particularly in the area of vascular endothelial cell growth factor (VEGF) variants. With a total of 3 patents to her name, her work has the potential to impact therapeutic applications significantly.

Latest Patents

Her latest patents include innovative pharmaceutical compositions that feature variants of vascular endothelial cell growth factor. These variants have modifications in the C-terminal heparin binding domain, which result in reduced clearance rates for systemic administration. This allows for effective therapeutic effects at lower doses compared to native VEGF, providing longer availability for treatment. Additionally, she has developed recombinant methods of production for these VEGF variants, further enhancing their therapeutic potential.

Career Highlights

Geralyn is currently associated with Genentech, Inc., a leading biotechnology company known for its focus on innovative medicines. Her work at Genentech has allowed her to explore and develop groundbreaking solutions in the pharmaceutical industry.

Collaborations

Throughout her career, Geralyn has collaborated with notable colleagues, including Thomas F Zioncheck and Rodney Gene Keck. These collaborations have contributed to her success and the advancement of her research.

Conclusion

Geralyn G DeGuzman is a trailblazer in the field of pharmaceutical innovations, with her work on VEGF variants paving the way for new therapeutic possibilities. Her contributions continue to influence the landscape of medical treatments.